Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

NCT05996731 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
105
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mario Negri Institute for Pharmacological Research